Complications of Laparoscopic Sleeve Gastrectomy by Using Four Ports: A Descriptive Study
Article Sidebar
Main Article Content
Abstract
Background: Obesity is a global health issue, with laparoscopic sleeve gastrectomy (LSG) emerging as a key surgical intervention. The use of a four-port approach in LSG is prevalent, yet it necessitates an evaluation of its safety and the scope of postoperative complications.
Objective: This study aims to evaluate the complications associated with the use of four ports in laparoscopic sleeve gastrectomy.
Methods: Conducted at Mumtaz Surgimed Hospital in Vehari, Punjab, this descriptive study involved thirty patients undergoing LSG with a four-port approach from May 1st to October 30th, 2023. The study assessed postoperative complications, with patients' BMI, comorbidities, and demographic data also considered.
Results: Participants had a mean age of 48.53 ± 5.91 years, with females comprising 63.3% and males 36.7%. Postoperative complications included gastroesophageal reflux disease (GERD) in 5 patients (16.7%), dyspepsia in 4 (13.3%), pulmonary issues in 2 (6.7%), bleeding in 3 (10%), and gastric stenosis in 1 (3.3%). There was a notable reduction in BMI from 47.69 ± 4.24 kg/m² to 40.03 ± 3.31 kg/m².
Conclusion: The four-port laparoscopic sleeve gastrectomy is a relatively safe surgical option for obesity treatment, with a low incidence of postoperative complications.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Salminen P, Helmiö M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P, Hurme S, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241-54.
Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255-65.
Gadiot RP, Biter LU, van Mil S, Zengerink HF, Apers J, Mannaerts GH. Long-term results of laparoscopic sleeve gastrectomy for morbid obesity: 5 to 8-year results. Obes Surg. 2017;27:59-63.
Palermo M, Serra E. Laparoscopic sleeve gastrectomy: how do I do it. J Laparoendosc Adv Surg Tech. 2020;30(1):2-5.
Lalezari S, Musielak MC, Broun LA, Curry TW. Laparoscopic sleeve gastrectomy as a viable option for an ambulatory surgical procedure: our 52-month experience. Surg Obes Relat Dis. 2018;14(6):748-50.
Bangash A, Khan MF, Azeem SM, Hussain A. Frequency of early complications of laparoscopic sleeve gastrectomy, using four ports, for morbidly obese patients in population of Khyber Pakhtunkhwa province, Pakistan. Pak J Surg. 2021;37(2):9-15.
Park Y, Park YS, Lee S, Kang SH, Lee E, Ahn SH, et al. Safety and effectiveness of reduced-port laparoscopic sleeve gastrectomy in Asian morbidly obese patients. Sci Rep. 2021;11(1):23511.
Macfater H, Xia W, Srinivasa S, Hill AG. Evidence-based management of postoperative pain in adults undergoing laparoscopic sleeve gastrectomy. World J Surg. 2019;43:1571-80.
Woźniewska P, Diemieszczyk I, Hady H. Complications associated with laparoscopic sleeve gastrectomy–a review. Gastroenterol Rev. 2021;16(1):5-9.
El Chaar M, Stoltzfus J. Assessment of sleeve gastrectomy surgical technique: first look at 30-day outcomes based on the MBSAQIP database. J Am Coll Surg. 2018;227(6):564-72.
Rosenberg JM, Tedesco M, Yao DC, Eisenberg D. Portal vein thrombosis following laparoscopic sleeve gastrectomy for morbid obesity. JSLS. 2012;16(4):639-42.
Alsina E, Ruiz-Tovar J, Alpera MR. Incidence of deep vein thrombosis and thrombosis of the portal–mesenteric axis after laparoscopic sleeve gastrectomy. J Laparoendosc Adv Surg Tech. 2014;24(9):601-5.
Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016;5:2048004016633371.
Wojciak P, Pawluszewicz P, Diemieszczyk I, et al. Laparoscopic sleeve gastrectomy: a study of efficiency in treatment of metabolic syndrome components, comorbidities and influence on certain biochemical markers. Videosurgery Miniinv. 2020;15:136-47.
Isoma B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16.
Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29:782-95.
Bangash A, Khan MF, Azeem SM, Hussain A. Frequency of early complications of laparoscopic sleeve gastrectomy, using four ports, for morbidly obese patients in population of Khyber Pakhtunkhwa province, Pakistan. Pak J Surg. 2021;37(2).
Tognoni V, Benavoli D, Bianciardi E, Perrone F, Ippoliti S, Gaspari A, Gentileschi P. Laparoscopic sleeve gastrectomy versus laparoscopic banded sleeve gastrectomy: first prospective pilot randomized study. Gastroenterol Res Pract. 2016;2016:6419603.